Briviact 75mg Tablet
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Brivaracetam (75mg)
Overview Briviact 75mg Tablet
Carbamazepine 75mg tablets are an anticonvulsant medication prescribed to manage epileptic seizures. This medication can be administered independently or in conjunction with other therapies. Its effectiveness in seizure prevention is contingent upon consistent usage. Carbamazepine 75mg tablets regulate abnormal brain electrical activity. Daily intake, with or without food, is recommended at the same time for optimal results. Dosage frequency is determined by your physician to effectively control seizures and may be adjusted incrementally. It's typically a long-term treatment; continued use, as directed by your doctor, is crucial even with symptom improvement. Discontinuing or missing doses may exacerbate seizures. Never cease treatment without your doctor's explicit instruction, as abrupt cessation can worsen seizures. Common adverse effects include vertigo, cephalalgia, nausea, and emesis. Behavioral shifts, aggression, irritability, and agitation may also occur. Side effects are more prevalent initially, often diminishing with continued use. While many side effects require no intervention, some are serious. Suicidal ideation has been reported in a small percentage of patients. Report any mood deterioration to your doctor immediately. Prior to commencing treatment, inform your doctor of any hepatic or renal impairment, depressive disorders, suicidal tendencies, pregnancy, or pregnancy intentions. Nursing mothers should also seek medical counsel before using this medication.
Uses of Briviact 75mg Tablet
Convulsive disorders
Major Benefits of Briviact 75mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Briviact 75mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Briviact 75mg Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Briviact 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Briviact 75mg Tablets can be consumed with or without food, however, consistent daily timing is recommended.
How Briviact 75mg Tablet works:
Carbamazepine 75mg tablets are used to control seizures. Their mechanism involves binding to voltage-gated sodium channels (SV2A), thus reducing excessive neuronal firing and preventing the propagation of seizure-inducing electrical impulses within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Briviact 75mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Briviact 75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Briviact 75mg tablets with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a 75mg Briviact tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Briviact 75mg tablets are considered safe, and no dosage modification is advised. However, their use is not recommended in cases of end-stage renal disease, given the absence of supporting clinical study results.
LiverCAUTION
Patients with hepatic impairment should use Briviact 75mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Briviact 75mg Tablet :
NA
Facts to Know About Briviact 75mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | AED: A protein ligand bound to synaptic vesicle 2 |



